Professor James has degrees in medicine and immunology from the University of London and a PhD from Imperial College in cell cycle biology. He undertook postgraduate training in London, Brussels and Tokyo and is a Fellow of the Royal Colleges of Radiology and Physicians.
His work focuses on evaluating and improving clinical trials to achieve better patient outcomes. He evaluates new treatment approaches to both bladder and prostate cancers via large multi-centre clinical trials and actively collaborates with laboratory groups to explore the underlying mechanisms at play in trials.
Clinical trials are the ultimate means of translating scientific advances into real gains in patient survival, or improvements in related outcomes such as prevention of unpleasant complications.
They require collaboration of many (often thousands) of participants, both as patients and in the clinical teams recruiting and managing the studies. Good design is thus key for optimising the conduct of trials to maximise return on investment.